The positive CREST study (BCG + Sasanlimab) in NMIBC was published today (Neal Shore et al). #ASCO25

🎯 #ASCO2025 Ev-302 update data in regards of ORR. @shilpaonc >> OS for responders pts ( more in CR pts-not reached) Ev-Pembro continue showing the efficacy in 1L mUC! @OncoAlert @tompowles1 @DrYukselUrun @GuardConsortium @ASCO @PGrivasMDPhD

#ASCO25 abstracts titlkes are out!!!!! https://t.co/ybAeFhH4He Much Looking forward to seeing the exciting new data in GU tumors!!!! See you all in Chicago!!!! @ASCO @ASCOPost @DrChoueiri @tompowles1 @shilpaonc @Heijden @motzermd @GuardConsortium

Pfizer’s Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer | Pfizer First phase III study with ICI’s in NMIBC!!👏👏👏

📖🇩🇪German guideline for esophageal SCC and adenoca @myESMO ✅Excellent guideline from diagnosis, imaging to nutrition, palliative care 👉 https://t.co/CyktqRo32d PS: I think there is a typing error in the algorithm of SCC. It should be "preoperative CRT" instead of

🌟 ESCC Innovation 🌟 The Phase III RATIONALE 302 trial is exploring tislelizumab (PD-1 inhibitor) for esophageal squamous cell carcinoma (ESCC), showing promising results in survival and quality of life. At @ApicesSpain we’re committed to advancing #oncology research. #CRO

New hope for #MultipleMyeloma! #Clinicaltrials are achieving promising results for patients. Phase III TILVANCE-30 trial, Phase II IOV-COM-202 trial for metastatic #melanoma and a Phase I trial studying the combination of Fianlimab and Cemiplimab for advanced melanoma stand out.

🌍The @WHO recommends the R21/Matrix-M vaccine for malaria prevention in children. With high efficacy, it’s a major step forward in the fight against malaria, particularly in Africa. #Malaria #Vaccines #CRO #ClinicalResearch https://t.co/XMseSCTKXr

🔬 Promising results 𝗳𝗿𝗼𝗺 𝗮 𝗣𝗵𝗮𝘀𝗲 𝗜𝗜𝗜 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹, the @EMA_News has approved 𝗹𝗲𝗰𝗮𝗻𝗲𝗺𝗮𝗯 to slow the progression of symptoms associated with #𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿'𝘀 𝗱𝗶𝘀𝗲𝗮𝘀𝗲. https://t.co/lhq8iXSrbA #CRO #ClinicalResearch #ClinicalTrials

In the fight against #HIV, the most recent advances in #clinicaltrials offer new hope for a future without this disease. The VIR-1388 trial, currently in phase I, aims to generate a strong and lasting immune response, which could transform HIV prevention. #CRO #ClinicalResearch

The STEM-PD #clinicaltrial is investigating the transplantation of dopamine-producing neurons derived from embryonic stem cells in patients with moderate #Parkinsons disease, aiming to replace the damaged cells and pave the way for regenerative therapies.  https://t.co/oha8F5aJUK

A patient achieved complete remission of a previously incurable #braintumor in a Phase I clinical trial through #CARTcell therapy. This breakthrough offers hope for pathologies once considered untreatable, and underscores the importance of #clinicaltrials. https://t.co/EFJRxZsZ8T

At #ESMO2024, key advancements were presented in #clinicaltrials that are revolutionizing #lungcancer treatment.  At @ApicesSpain, we are committed to the development of innovative treatments in #oncology, transforming cancer therapies and offering new hope to patients. #CRO

At @ApicesSpain we believe #patients should be at the heart of #clinicaltrials. Through proactive engagement we ensure that studies are designed with their needs, concerns and hopes as a priority. https://t.co/JeqSFuRPXt   #CRO

#Breastcancer is a major health challenge globally, with high morbidity and mortality. At the recent #ESMO24 congress, several promising new treatments were presented that could significantly improve outcomes for patients: 🎗️DESTINY-Breast06 trial 🎗️ ABIGAIL trial #CRO #Oncology

Promising #clinicaltrials show advances in bispecific antibodies and CAR-T therapies for #multiplemyeloma, offering hope for better outcomes and quality of life. #clinicalresearch https://t.co/z9aOxcf46J

Spain is the European country with the highest number of #CTIS authorized #clinicaltrials! This highlights the excellence of our healthcare system and investigators. #clinicalresearch   https://t.co/ZB4PeGf2J6

🌟 Exciting news! A #clinicaltrial is testing a vaccine that could revolutionize #lungcancer treatment by activating the immune system. #CRO #Clinicalresearch https://t.co/m59nXQPGXp

🎉 We celebrate a major milestone! The Spanish’s REEC has reached 10k published #clinicaltrials. At @ApicesSpain we’re proud to contribute to #clinicalresearch and advance innovative treatments! #CRO https://t.co/9X4ONP57DT

#Clinicaltrials show immunotherapy boosts survival in advanced Hodgkin’s #lymphoma, offering new therapeutic avenues. #Clinicalresearch #Oncology #Immunotherapy https://t.co/3cyLEigIrv